SYNOKEM Pharmaceuticals Ltd.
Synokem Pharmaceuticals Ltd started its operations in the 1982, with a vision of empowering life with quality medicines on competitive prices and timely availability to each segment of population.
Started operations with own ethical marketing and in year 2005 management took a strategic decision to establish own manufacturing site. Synokem Pharma came up with its own WHO-GMP plant in year 2006.
With all best efforts from management and quality staff, soon the SYNOKEM PHARMA became a renowned name among the top companies such as ZYDUS, MANKIND, ABBOTT, CIPLA, SUNPHARMA and many more for their contract manufacturing requirements.
All such companies are with us since the inception of SYNOKEM PHARMA and the relations are getting stronger.
• Strong R&D, QC (GLP certified) and QA team.
• Launching of new molecules for contract manufacturing parties and for self-export market
• Focused QC /QA team which work on molecules those are going to off patent in next 5 years.
• Products in pipe line (under development), more than 150
• First company in India to launch AZILSARTAN
• Only company in world to have Progesteron tab SR technique
• Capable to work on turnkey projects / tech transfers
• Strong regulatory teams for domestic and export requirements.
Turnover / Infrastructure / Technology
At Synokem, management understands the value of ever-changing technology, and investing heavily to keep itself abreast with the latest changes in pharma industry. With latest independent lab that is equipped with all modern QC apparatus, Synokem is ready to perform all related drug test in house only.
In 2015, to meet the product demand of clients on given time, management has invested into new manufacturing plant, which is designed as per US FDA norms.
With the support of all prominent clients, SYNOKEM has touched the mark of USD 90 mn for last FY, i.e. INR 500 + Cr.
Synokem also have plans to come up with different therapeutic segment and the concerned teams are working on same.
Synokem Pharmaceuticals works on 4 business verticals and expanded well in all with dedicated departments / teams.
1. Contract Manufacturing
2. Ethical division (More than 150 medical reps)
3. Institutional sales (participating all big hospital tenders / state tenders)
4. Export Division
The parallel diversifications made by synokem management in strategic way and on right intervals. Initial focus was on contract mfg and institutional sale after plant came into existence and launched its own ethical team thereafter. The Ethical team has now coverage of East / North and West part of India.
Overseas Venture / future aspects:-
Synokem Management has clear vision to excel in overseas markets and for same they launched export division with separate regularly department in year 2014.
In recent past, Synokem has made its marks in various overseas markets with accreditations from different FDAs.
Synokem: - International Approvals / Presence / Export status
SEA & FDAs Cambodia Philippines Myanmar
MOH PFDA Registered
SAARC Srilanka Bhutan Nepal Afghanistan
CDDA MOH DDA Active
Latam Peru Ecudaor Chile Venezuela
Active Active Active Only Tender
CIS Uzbekistan Armenia Serbia Gerogia Krgyzstan
Active Bulk supply Active Active In process
Others Yemen Qatar Oman
Audit filed Under Registration Filing in process
Kenya Uganda Ghana Nigeria Ivory Coast
Africa & FDA`s PPB NDA FDA NAFDAC DPM
Zambia Tanzania Ethiopia Botswana DRC
Registered Audit Filed Audit Filed Under Registration Active
Synokem Agenda for future:-
The future plan for Synokem is to get its facility audited successfully from,
For the same, the QA / QC teams are working on documentary part and all together are gearing up for it with a target to achieve same by 2020.
|Sales markets||Asia; Africa; Central/South America|
|Primary business activity||Distributor; Manufacturer|
|Affiliated categories:||Drug Formulation (general category) |Tablets More|
CPhI Worldwide 20195-7 November 2019 Frankfurt, Germany We were at stand 90D90 See our Exhibitor Profile See full Exhibitor List
CPhI & PMEC India 201812-14 December 2018 India Expo Centre, Greater Noida, Delhi NCR We were at stand 5.H02 See our Exhibitor Profile See full Exhibitor List
Our Top products
Pregabalin 75mg+Methylcobalamin 750 mcg Capsules
Synokem pharmaceuticals offers a wide range of products which includes pregabalin 75mg+methylcobalamin 750 mcg capsules. Dosage: 3 x 10 alu-alu strip pack. Contact us for more information.More info
Progesterone Sustained Release Tablets 100 mg
Synokem pharmaceuticals offers a wide range of hormones products which includes progesterone sustained release tablets 100 mg. Dosage: 3x10 blister pack. Contact us for more information.More info
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation